NRTX-1001 ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
141	Mesial temporal lobe epilepsy with hippocampal sclerosis	1

141. Mesial temporal lobe epilepsy with hippocampal sclerosis

Clinical trial : 1 / Drug : 1 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05135091 (ClinicalTrials.gov)	June 16, 2022	16/11/2021	FIH Study of NRTX-1001Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy ...	A First-In-Human (FIH) Study of Inhibitory Interneurons (NRTX- 1001) in Drug-Resistant Unilateral Me ...	Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis	Biological: NRTX-1001;Procedure: Sham Comparator	Neurona Therapeutics	California Institute for Regenerative Medicine (CIRM)	Recruiting	18 Years	55 Years	All	40	Phase 1/Phase 2	United States

First Previous1Next Last